Bio-Rad Laboratories, Inc.Class A (BIO)
NYSE · Manufacturing · Laboratory analytical instruments
BIO price, last 12 months
Key stats
- Previous close
- $387.54
- Open
- $384.14
- Day range
- $376.43 – $387.00
- 52-week range
- $236.73 – $396.23
- Volume
- 253.6K
- Avg volume (20 days)
- 270K
- Market cap
- $10.2B
Performance
Technicals and fundamentals
About Bio-Rad Laboratories, Inc.Class A
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
- Sector
- Manufacturing
- Industry
- Laboratory analytical instruments
- Listed on
- NYSE
- Market cap
- $10.2B